TaqIB and severity of coronary artery disease in the Turkish population: a pilot study

  • Dilara Kaman Department of Biochemistry, Faculty of Medicine, Firat University, Elazig
  • Necip İlhan Department of Biochemistry, Faculty of Medicine, Firat University, Elazig
  • Nevin İlhan Department of Biochemistry, Faculty of Medicine, Firat University, Elazig
  • Mehmet Akbulut Department of Cardiology, Faculty of Medicine, Firat University, Elazig
Keywords: CETP, coronary artery disease, HDL-C

Abstract

The cholesteryl ester transfer protein (CETP) plays a crucial role in high-density lipoprotein (HDL) metabolism. Genetic variants that alter CETP concentration may cause significant alterations in HDL-cholesterol (HDL-C) concentration. In this case-control study, we analyzed the genotype frequencies of CETP Taq1B polymorphisms in coronary artery disease patients (CAD; n=210) and controls (n=100). We analyzed the role of the CETP Taq1B variant in severity of CAD, and its association with plasma lipids and CETP concentration. DNA was extracted from 310 patients undergoing coronary angiography. The Taq1B polymorphism was genotyped using polymerase chain reaction—restriction fragment length polymorphism (RFLP) analysis. Lipid concentrations were measured by an auto analyzer and CETP level by a commercial enzyme-linked immunosorbent assay (ELISA) kit.  In our study population, the B2 allele frequency was higher in control subjects than patients with single, double or triple vessel disease.  B2B2 genotype carriers had a significantly higher high-density lipoprotein cholesterol (HDL-C) concentration than those with the B1B1 genotype in controls (51.93±9.47versus 45.34±9.93; p<0.05) and in CAD patients (45.52±10.81 versus 40.38±9.12; p<0.05). B2B2 genotype carriers had a significantly lower CETP concentration than those with the B1B1 genotype in controls (1.39±0.58 versus 1.88±0.83; p< 0.05) and in CAD patients (2.04±1.39versus 2.81±1.68; p< 0.05). Our data suggest that the B2 allele is associated with higher concentrations of HDL-C and lower concentrations of CETP, which confer a protective effect on coronary artery disease.  

 

Downloads

Download data is not yet available.

Author Biography

Dilara Kaman, Department of Biochemistry, Faculty of Medicine, Firat University, Elazig
department of biochemistry

References

White DA, Baxter M. Hormones and Metabolic Control. 2nd ed. London: Arnold; 1994.

Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K,et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990;323:1234-1238.http://dx.doi.org/10.1056/NEJM199011013231803

Inazu A, Jiang XC, Haraki T, Yagi K, Kamon N, Koizumi J,et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 1994;94:1872-1882.

http://dx.doi.org/10.1172/JCI117537

Freeman DJ, Packard CJ, Shepherd J, Gaffney D. Polymorphisms in the gene coding for cholesterol ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci 1990;79:575–581.

http://dx.doi.org/10.1161/01.ATV.17.3.560

Kuivenhoven JA, de Knijff P, Boer JM, Smalheer HA, Botma GJ, Seidell JC,et al. Heterozygosity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997; 17: 560–568.

http://dx.doi.org/10.1161/01.ATV.17.3.560

Kark JD, Sinnreich R, Leitersdorf E, Friedlander Y, Shpitzen S, Luc G. Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. Atherosclerosis 2000;151: 509–518.

http://dx.doi.org/10.1016/S0021-9150(99)00408-6

Agellon LB, Walsh A, Hayek T, Moulin P, Jiang XC, Shelanski SA,et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 1991;97:2917–2923.

Inazu A, Koizumi J, Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr Opin Lipidol 2000;11(4):389–396.

http://dx.doi.org/10.1097/00041433-200008000-00008

Drayna D, Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 1987;15(11):4698.

http://dx.doi.org/10.1093/nar/15.11.4698

Freeman D, Shepherd J, Packard CJ, Humphries SE, Gaffney D. An StuI RFLP at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 1989;17(7):2880.

http://dx.doi.org/10.1093/nar/17.7.2880

Zuliani G, Hobbs HH. EcoN I polymorphism in the human cholesteryl ester transfer protein (CEPT) gene. Nucleic Acids Res 1990;18(9):2834.

http://dx.doi.org/10.1093/nar/18.9.2834-a

Yamashita S, Hirano K, Sakai N, Matsuzawa Y. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim Biophys Acta 2000;1529(1-3):257-275.

http://dx.doi.org/10.1016/S1388-1981(00)00164-5

Bernard S, Moulin P, Lagrost L, Picard S, Elchebly M, Ponsin G, et al. Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. J Lipid Res 1998;39(1):59-65.

Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high-density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995;96(3):1664-1671.

http://dx.doi.org/10.1172/JCI118207

Gudnason V, Kakko S, Nicaud V, Savolainen MJ, Kesäniemi YA, Tahvanainen E, et al. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest 1999;29(2):116-128.

http://dx.doi.org/10.1046/j.1365-2362.1999.00412.x

Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. TheRegression Growth Evaluation Statin Study Group. N Engl J Med 1998;338(2):86-93.

http://dx.doi.org/10.1056/NEJM199801083380203

Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, et al. Association of cholesteryl ester transfer protein TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 2000;20(5):1323-1329.

http://dx.doi.org/10.1161/01.ATV.20.5.1323

Corbex M, Poirier O, Fumeron F, Betoulle D, Evans A, Ruidavets JB, et al. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene–environment interaction. Genet Epidemiol 2000;19(1):64–80.

http://dx.doi.org/10.1002/1098-2272(200007)19:1<64::AID-GEPI5>3.0.CO;2-E

Arca M, Montali A, Ombres D, Battiloro E, Campagna F, Ricci G, et al. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Clin Genet 2001;60(5):374–380.

http://dx.doi.org/10.1034/j.1399-0004.2001.600510.x

Cuchel M, Wolfe ML, deLemos AS, Rader DJ. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians. Atherosclerosis 2002;163(2):169–174.

http://dx.doi.org/10.1016/S0021-9150(01)00769-9

Eiriksdottir G, Bolla MK, Thorsson B, Sigurdsson G, Humphries SE, Gudnason V. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis 2001;159(1):187-192.

http://dx.doi.org/10.1016/S0021-9150(01)00489-0

Park KW, Choi JH, Kim HK, Oh S, Chae IH, Kim HS, et al. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans. Clin Genet 2003;63(1):31-38.

http://dx.doi.org/10.1034/j.1399-0004.2003.630105.x

Radeau T, Vohl MC, Houde I, Lachance JG, Noël R, Després JP,et al. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients. Nephron 2000;84(4):333-341.

http://dx.doi.org/10.1159/000045608

Blankenberg S, Rupprecht HJ, Bickel C, Jiang XC, Poirier O, Lackner KJ, et al. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease. J Am Coll Cardiol 2003;41(11):1983–1989.

http://dx.doi.org/10.1016/S0735-1097(03)00408-X

Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829–1839.

http://dx.doi.org/10.1016/S0140-6736(07)61778-4

Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med.2007;357(13):1301–1310.

http://dx.doi.org/10.1056/NEJMoa064278

Yilmaz H, Isbir T, Agachan B, Karaali ZE. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochem Funct 2005;23(1):23–28.

http://dx.doi.org/10.1002/cbf.1124

Chen SN, Cilingiroglu M, Todd J, Lombardi R, Willerson JT, Gotto AM Jr,et al. Candidate genetic analysis of plasma highdensity lipoprotein-cholesterol and severity of coronary atherosclerosis. BMC Med Genet 2009; 10:111.

http://dx.doi.org/10.1186/1471-2350-10-111

Kuivenhoven JA, de Knijff P, Boer JM, Smalheer HA, Botma GJ, Seidell JC, et al. Heterozygosity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997;17:560–568.

http://dx.doi.org/10.1161/01.ATV.17.3.560

Kolovou GD, Anagnostopoulou KK, Karyofillis P, Salpea KD, Yiannakouris N, Zarkalis D, et al. Cholesteryl ester transfer protein gene polymorphisms and severity of coronary stenosis. Clin Invest Med 2006;29(1):14–19.

http://dx.doi.org/10.1016/j.atherosclerosis.2007.12.038

Tsai MY, Johnson C, Kao WH, Sharrett AR, Arends VL, Kronmal R, et al. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2008;200(2):359–367.

http://dx.doi.org/10.1016/j.atherosclerosis.2007.12.038

Doğru-Abbasoğlu S, Parildar-Karpuzoğlu H, Depboylu B, Cine N, Uysal M, Aykaç-Toker G.I405V and TaqIB polymorphisms of the cholesteryl ester transfer protein and their relation to serum lipid and lipoprotein levels in a Turkish population. Cell Biochem Funct 2009; 27(2):76–80.

http://dx.doi.org/10.1002/cbf.1536

TaqIB and severity of coronary artery disease in the Turkish population: a pilot study
Published
2015-02-01
How to Cite
1.
Kaman D, İlhan N, İlhan N, Akbulut M. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study. Bosn J of Basic Med Sci [Internet]. 2015Feb.1 [cited 2020Sep.22];15(1):9-13. Available from: http://bjbms.org/ojs/index.php/bjbms/article/view/157
Section
Biochemistry